首页> 外文OA文献 >Epidemiology of uromodulin-associated kidney disease - results from a nation-wide survey.
【2h】

Epidemiology of uromodulin-associated kidney disease - results from a nation-wide survey.

机译:尿调节蛋白相关的肾脏疾病的流行病学-一项全国性调查的结果。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND/AIMS: Uromodulin-associated kidney disease (UAKD) is caused by uromodulin mutations and leads to end-stage renal disease. Our objective was to examine the epidemiology of UAKD. METHODS: Data from all UAKD families in Austria were collected. Patients included in the Austrian Dialysis and Transplantation Registry (OEDTR) with unclear diagnoses or genetic diseases were asked whether they had (1) a family history of kidney disease or (2) had suffered from gout. Patients with gout and autosomal dominant renal disease underwent mutational analysis. Kaplan-Meier and Cox analysis was employed to estimate time to renal failure. RESULTS: Of the 6,210 patients in the OEDTR, 541 were approached with a questionnaire; 353 patients answered the questionnaire. Nineteen of them gave two affirmative answers. In 7 patients, an autosomal dominant renal disease was found; in 1 patient a UMOD mutation was identified. One family was diagnosed through increased awareness as a consequence of the study. At present, 14 UAKD patients from 5 families are living in Austria (1.67 cases per million), and 6 of them require renal replacement therapy (0.73 per 1,000 patients). Progression to renal failure was significantly associated with UMOD genotype. CONCLUSION: UAKD patients can be identified by a simple questionnaire. UMOD genotype may affect disease progression.
机译:背景/目的:尿调节蛋白相关的肾脏疾病(UAKD)是由尿调节蛋白突变引起的,并导致终末期肾脏疾病。我们的目标是检查UAKD的流行病学。方法:收集了奥地利所有UAKD家庭的数据。询问包括在奥地利透析和移植登记处(OEDTR)中且诊断或遗传病不清楚的患者,他们是否具有(1)肾脏疾病家族史或(2)患有痛风。患有痛风和常染色体显性遗传性肾脏疾病的患者进行了突变分析。使用Kaplan-Meier和Cox分析来估计肾衰竭的时间。结果:在OEDTR的6,210名患者中,有541名接受了问卷调查。 353名患者回答了问卷。其中有19个回答是肯定的。在7名患者中,发现了常染色体显性遗传性肾脏疾病。在1例患者中发现了UMOD突变。该研究的结果是通过提高认识来诊断出一个家庭。目前,来自5个家庭的14名UAKD患者居住在奥地利(每百万人中有1.77例),其中6人需要进行肾脏替代治疗(每千名患者中有0.73例)。肾衰竭的进展与UMOD基因型显着相关。结论:可以通过简单的问卷来识别UAKD患者。 UMOD基因型可能影响疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号